Preview | Asset Purchase Agreement |

Document Preview

Asset Purchase Agreement

Click "Add to Cart" button to purchase document.
Documents are emailed immediately after purchase.
You can also browse documents by title, category, or company... or click here for help finding documents.

Title:

Asset Purchase Agreement

Entities:

Aether Holdings Inc

Date:

2007

Size:

Preview shows 38KB of 103KB total

Price:

$49

ID:

#2850895

► Purchase & Sale ► Purchase ► Asset Purchase Agreements

Start of Preview

ASSET PURCHASE AGREEMENT

by and between

INTERMUNE, INC.

and

TARGANTA THERAPEUTICS CORPORATION

dated as of December 23, 2005

TABLE OF CONTENTS


		Page
Article 1. Definitions		1

Section 1.01	Defined Terms	1
Section 1.02	Construction of Certain Terms and Phrases	1

Article 2. Purchase and Sale of Assets		1

Section 2.01	Purchase and Sale of Assets	1
Section 2.02	Transition Services	2
Section 2.03	Assignability and Consents	2

Article 3. Assumption of Assumed Liabilities		2

Article 4. Purchase Price and Payment		2

Section 4.01	Purchase Price	2
Section 4.02	Purchase of Product Inventory	3
Section 4.03	Payment of Sales, Use and Other Taxes	3
Section 4.04	Impact of Failure to Issue Notes or Make Payments Thereunder	3
Section 4.05	Allocation of Purchase Price	3

Article 5. Closing		4

Section 5.01	Time and Place	4
Section 5.02	Deliveries at Closing	4

Article 6. Representations and Warranties of Seller		6

Section 6.01	Organization, Etc.	6
Section 6.02	Authority; Binding Nature	6
Section 6.03	Non-Contravention; Consents	6
Section 6.04	Purchased Assets	6
Section 6.05	Title to Purchased Assets	6
Section 6.06	Assumed Contracts	6
Section 6.07	Intellectual Property Rights	7
Section 6.08	Litigation	8
Section 6.09	No Debarment; Permits	8
Section 6.10	Purchased Product Inventory	9
Section 6.11	Product Data	9
Section 6.12	Brokers	9
Section 6.13	No Other Representations	9

Article 7. Representations and Warranties of Buyer		10

Section 7.01	Organization, Etc.	10
Section 7.02	Authority; Binding Nature of Agreement	10


Section 7.03	Non-Contravention; Consents	10
Section 7.04	Litigation	10
Section 7.05	Brokers	10

Article 8. Covenants of the Parties		10

Section 8.01	Public Announcements	10
Section 8.02	Non-Solicitation	11
Section 8.03	Corporate Names	11
Section 8.04	Regulatory Matters	11
Section 8.05	Adverse Experience Reports	11
Section 8.06	Affiliates	11
Section 8.07	Access	11
Section 8.08	Non-Competition	12
Section 8.09	Use of Proceeds	12
Section 8.10	Further Assurances	12
Section 8.11	Diligence	12

Article 9. Conditions to the Obligations of Seller		13

Section 9.01	Representations, Warranties and Covenants	13
Section 9.02	No Actions or Proceedings	13
Section 9.03	Consents	13
Section 9.04	Buyer Restructuring	13
Section 9.05	Investor Convertible Notes	13
Section 9.06	Other Closing Deliveries	13

Article 10. Conditions to the Obligations of Buyer		14

Section 10.01	Representations, Warranties and Covenants	14
Section 10.02	No Actions or Proceedings	14
Section 10.03	Consents	14
Section 10.04	Lilly Agreement	14
Section 10.05	Purchased Assets	14
Section 10.06	Other Closing Deliveries	14

Article 11. Indemnification		14

Section 11.01	Survival of Representations, Warranties, Etc.	14
Section 11.02	Indemnification	15
Section 11.03	Limitations	17
Section 11.04	Consequential Damages	18

Article 12. Miscellaneous		19

Section 12.01	Confidentiality	19
Section 12.02	Notices	19
Section 12.03	Entire Agreement	20
Section 12.04	Waiver	20
Section 12.05	Amendment	20
Section 12.06	Third Party Beneficiaries	20


Section 12.07	Assignment; Binding Effect	20
Section 12.08	Headings	21
Section 12.09	Severability	21
Section 12.10	Governing Law; Dispute Resolution	21
Section 12.11	Expenses	21
Section 12.12

End of Preview

Home Intelligence Services Subscriptions News About Us